AI assistant
Capstone Holding Corp. — Director's Dealing 2016
Aug 2, 2016
35323_dirs_2016-08-02_f8de5c26-d621-4066-963b-a964c26098d4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2016-08-01
Reporting Person: MILLER LLOYD I III (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-08-01 | Common Stock | S | 80000 | $0.0608 | Disposed | 5844968 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 472792 | Indirect |
| Common Stock | 90344 | Indirect |
| Common Stock | 641218 | Indirect |
| Common Stock | 724100 | Indirect |
| Common Stock | 58967 | Direct |
Footnotes
F1: The price in Column 4 is a weighted average price. The price actually paid ranged from $0.060 to $0.061 per share. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
F2: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. This filing shall not be deemed an admission that the reporting person is, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this filing.